Patient perception on risk of recurrence and decision-making in the management of HER2-positive early breast cancer: Insights from the ASKHER2 European survey
Results of this multinational direct-to-patient study examining the perceptions and concerns of women with HER2+ breast cancer underscore the need for physicians to proactively involve patients in their decision-making process, enabling them to participate in a patient-centred approach during treatment decisions.
Authors
- María Vidal (ORCID: https://orcid.org/0000-0003-1992-5727)
- Laure Guéroult-Accolas
- Christian Jackisch (ORCID: https://orcid.org/0000-0001-8537-3743)
- Olivier Trédan (ORCID: https://orcid.org/0000-0001-5881-9383)
- Mário Fontes-Sousa (ORCID: https://orcid.org/0000-0003-0337-3251)
- Rosanna D’Antona
- Olivia Dialla
- Antonios Valachis (ORCID: https://orcid.org/0000-0001-6059-0194)
- Matteo Lambertini (ORCID: https://orcid.org/0000-0003-1797-5296)
- Soraia Matos
- Erwan Berjonneau
- Eugenia Krone
- Miriam Brice
- Marcelo Ruz
Institutions
- Centre National de la Recherche Scientifique (FR)
- Oracle (United States) (US)
- Inserm (FR)
- Pierre Fabre (Germany) (DE)
- Örebro University (SE)
- Patients First (US)
- Hospital Clínic de Barcelona (ES)
- Luohe Medical College (CN)
- Centre de Recherche en Cancérologie de Lyon (FR)
- Laboratory Krone (DE)
- Hospital of St. Francis Xavier (PT)
- Pierre Fabre (France) (FR)
- Europa Donna (IT)
- Kliniken Essen-Mitte (DE)
- Ospedale Policlinico San Martino (IT)
- Fresenius Medical Care (Germany) (DE)
Publication Details
- Journal
- The Breast
- Published
- 2025-03-22
- DOI
- https://doi.org/10.1016/j.breast.2025.104456
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- Les Laboratories Pierre Fabre
- Fondation Pierre Fabre